- Conference call and webcast today at 4:30 p.m. ET - SEATTLE --(BUSINESS WIRE)--Nov. 12, 2020-- Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune / inflammatory diseases, today provided a